- Home
- PCVX vs FHN Comparison
PCVX vs FHN Comparison
Compare PCVX & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | FHN |
|---|---|---|
| Founded | 2013 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 11.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | FHN |
|---|---|---|
| Price | $48.11 | $24.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $101.67 | $24.61 |
| AVG Volume (30 Days) | 1.5M | ★ 5.7M |
| Earning Date | 11-04-2025 | 01-15-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | ★ 20.88 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $3,184,000,000.00 |
| Revenue This Year | N/A | $12.70 |
| Revenue Next Year | N/A | $2.54 |
| P/E Ratio | ★ N/A | $14.76 |
| Revenue Growth | N/A | ★ 3.68 |
| 52 Week Low | $27.66 | $15.19 |
| 52 Week High | $93.77 | $24.44 |
Technical Indicators
Market Signals| Indicator | PCVX | FHN |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 74.40 |
| Support Level | $42.40 | $23.54 |
| Resistance Level | $45.15 | $24.10 |
| Average True Range (ATR) | 1.94 | 0.46 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 91.30 | 96.09 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.